Product Type Antibody
Description The monoclonal antibody 2D5B6 specifically reacts with human MAP-44. The protein is approximately 44kDa and is encoded by another spliced mRNA of the MASP-1 gene. So far, five MASP proteins (MASP-1, MASP-2, MASP-3, MAp19 and MAp44) encoded by two genes have been identified. The MASP-2 gene produces MASP2 and MAp19 due to alternative splicing, while the MASP-1 gene encodes a primary transcript that can be spliced into three different mRNAs encoding MASP-1, MASP-3 and MAp44. At the protein level, MASP-1 and MASP-2 are responsible for complement activation through proteolysis of C2 and C4, while MASP-3 is believed to inhibit the production of C3 convertase. So far, the role of Map44 is still elusive. However, recent studies have shown that, compared with the level of Map44 in normal serum, patients with colorectal cancer have elevated levels of MAp44 after surgery. The monoclonal antibody 2D5B6 is suitable for immunohistochemistry, western blotting and immunoassay.
Disease Cardiology and metabolism, Infectious diseases
Size 100 µg
Immunogen MAp44 specific peptide
Species Human
Clonality Monoclonal
Clone Number 2D5B6
Buffer PBS, 0.1% bovine serum albumin and 0.02% sodium azide.
Application Immuno assays, Immuno precipitation, Paraffin sections, Western blot
Application Notes For immunohistochemistry, immunoprecipitation, immunoassay and western blot], the use of diluent depends on the detection system used. It is recommended that users test reagents and determine their own optimal dilution. The typical initial working dilution is 1:50.
Storage Instructions Product should be stored at 4°C. Under recommended storage conditions, product is stable for at least one year.
Alternative Names CRARF; PRSS5
Related Products
All products and services are for Research Use Only. Do Not use in humans.
Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.